Skip to main content
. 2018 Dec 20;16(1):11. doi: 10.3390/ijerph16010011

Figure 4.

Figure 4

PRISMA flow diagram for selection of cost-effectiveness studies for schistosomiasis and strongyloidiasis, 1993–2016. DARE: Database of Abstracts of Reviews of Effects; NHS EED: National Health Service Economic Evaluation Database; Tufts CEA: Tufts Medical Centre Cost-Effectiveness Analysis Registry.